Bioterm Pharmaceutical Ltd.
Bioterm Pharmaceutical Ltd. (BT) is a privately held pharmaceutical company engaged in developing innovative therapeutics for the treatment and prevention of pre-term labor and labor induction. The products candidates include Preventerm molecule, for the prevention of pre-term labor and Inducterm molecule, a human enzyme collagenase product used for the treatment of labor induction. The company commercializes its proprietary drugs through strategic partnerships with big pharmaceutical companies such as Abbott and Schering, Johnson & Johnson, Ferring, Organon and Akzo Nobel and other animal pharmaceutical companies. BT is currently focusing on the development of its products for veterinary markets. The company is headquartered in Tel Aviv, Israel.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

